The scientific advisory group on Covid immunisation has deferred “any decision on additional dose” in the absence of consensus on whether there is a need to administer a ‘booster’ to those at high risk of infection or severe illness caused by the coronavirus. “No recommendation has been made by the NTAGI yet,” a senior official told TOI.from India News | Latest News Headlines & Live Updates from India - Times of India
The scientific advisory group on Covid immunisation has deferred “any decision on additional dose” in the absence of consensus on whether there is a need to administer a ‘booster’ to those at high risk of infection or severe illness caused by the coronavirus. “No recommendation has been made by the NTAGI yet,” a senior official told TOI.via
0 Comments